Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
09/2010
09/08/2010CN101827822A Crystalline indazole-derived chemotherepeutic
09/08/2010CN101827821A Crystalline chemotherapeutic
09/08/2010CN101827820A Aminopyrazole amide derivative
09/08/2010CN101824000A Synthesis method of 1-methyl-3-trifluoromethyl pyrazol
09/08/2010CN101823999A 1,3,5-trisubstituted 4,5 - dihydro - 1H - pyrazole derivatives having CB1 - antagonistic activity
09/08/2010CN101823987A New DPP-IV inhibitors and preparation method and application thereof
09/08/2010CN101279946B Synthetic method of pyrazoles
09/07/2010US7790905 sodium salt of celecoxib
09/07/2010US7790761 alleviating vision defects, multiple sclerosis, neurodegenerative diseases, stroke, spinal cord injury, Alzheimer's disease, Parkinson's disease or pain, comprising administering sodium channel modulators comprising pyrazole or indazole derivatives, such as 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole
09/07/2010US7790743 Modulators of cellular adhesion
09/07/2010US7790711 Inhibitors of 11β-Hydroxysteroid Dehydrogenase
09/07/2010US7790704 3'-{N'-[1-(3,4-Dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2'-hydroxybiphenyl-3-carboxylic acid; thrombocytopenia and megakaryocytopoiesis treatment
09/07/2010CA2590533C 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/02/2010US20100222580 Process For The Preparation Of Onium Alkylsulfates Having A Low Halide Content
09/02/2010US20100222404 Indazole derivative dihydrochloride
09/02/2010US20100222330 New Compounds
09/02/2010US20100222317 Azetidine Derivatives as GlyT1 Inhibitors
09/02/2010US20100222275 Therapeutic agent for vitiligo and method of accelerating pigmentation
09/02/2010US20100222217 Fungicidal N-[2-(Haloalkoxy)Phenyl]Heteroarylcarboxamides
09/02/2010US20100221186 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
09/01/2010EP2223914A1 Tricyclic condensed pyrazole derivatives as CB1 inhibitors
09/01/2010EP2223913A1 Tricyclic pyrazole derivatives and microemulsions thereof as CB1- and/or CB2-inhibitors
09/01/2010EP2222639A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
09/01/2010EP2222638A2 Biaryl pde4 inhibitors for treating inflammation
09/01/2010EP2222160A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
09/01/2010EP1379508B1 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/01/2010EP1286969B1 Process for the preparation of pesticidal compounds
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN101821240A N- ( pyrazole- 3 -yl) -benzamide derivatives as glucokinase activators
09/01/2010CN101821239A 3-alkoxy-1-phenylpyrazole derivative and pest control agent
09/01/2010CN101821238A Compounds which inhibit BETA-SECRETASE activity and methods of use thereof
09/01/2010CN101820759A Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives
09/01/2010CN101817811A 1,3-dimethylbutyl carboxanilides for controlling undesirable micro-organisms
09/01/2010CN101817784A Ethylene derivatives and pesticides containing said derivatives
09/01/2010CN101817773A Preparation method of chiral alpha-non-natural amino acid
09/01/2010CN101817767A Substituted sulphonamide compound and preparation method, medicine composition and application thereof
09/01/2010CN101429163B Recovery processing method for waste material in pyrazolone production
08/2010
08/31/2010US7786165 Antidiabetic agents; obesity; insulin resistance; neurodegenerative diseases; Alzheimer's disease
08/31/2010US7786161 prostaglandin receptor antagonists such as 2-(2-((4-methyl-2-(naphthalen-1-yl)pentanoyl)amino)-4-(pyrazol-1-ylmethyl) benzyl)benzoic acid, used for the prevention and/or treatment of diseases induced pain, skin disorders, allergies, urogenital disorders, Alzheimer's disease, cancer and dysmenorrhea
08/31/2010US7786159 Thrombopoietin mimetics
08/31/2010US7786144 Sulphur containing pyrazole derivatives as selective cannabinoid CB1 receptor antagonists
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/31/2010US7786112 Small molecule antiproliferative agents
08/31/2010US7786045 fungicide, insecticide and miticide; 3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5 oxy derivatives
08/26/2010WO2010095024A2 An improved process for the preparation of celecoxib
08/26/2010WO2010094666A2 Fungicidal n-(phenylcycloalkyl)carboxamide, n-(benzylcycloalkyl)carboxamide and thiocarboxamide derivatives
08/26/2010WO2010076033A9 Toluidine sulfonamides and their use
08/26/2010WO2010066682A4 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
08/26/2010WO2010054003A3 Methylindazole modulators of 5-ht3 receptors
08/26/2010US20100216859 Curcumin analog compositions and related methods
08/26/2010US20100216849 Biphenylcarboxamides
08/26/2010US20100216827 Aryl gpr120 receptor agonists and uses thereof
08/26/2010US20100216803 Ornithine derivative
08/26/2010US20100216785 Pharmaceutical compositions
08/26/2010US20100215741 Pharmaceutical compounds
08/25/2010EP2221380A1 Method for producing hydroxylated adamantane using cytochrome p450
08/25/2010EP2221298A1 Phenylpyrazole derivatives
08/25/2010EP1931641B1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
08/25/2010EP1620082B9 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
08/25/2010EP1591443B1 Pyrazole derivative
08/25/2010EP1127050B1 Method for producing 1-substituted 5-hydroxypyrazoles
08/25/2010CN101815705A Method for producing pyrazolinone derivative
08/25/2010CN101812019A Compound containing pyrazole ring geranyl formate, preparation method and applications thereof
08/25/2010CA2694683A1 Pharmaceutical compounds
08/25/2010CA2694679A1 Pharmaceutical compositions
08/24/2010US7781960 Metal complex compound and organic electroluminescent element using the same
08/24/2010US7781592 Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same
08/24/2010US7781473 administering -Methyl-5-trifluoromethyl-3,4-dihydro-2H-pyrazole-3-carboxylic acid (4-cyano-3-trifluoromethyl-phenyl)-amide, for the treatment of benign prostatic hyperplasia, prostate carcinoma, hirsutism, alopecia, anorexia, breast cancer,acne, AIDS, cachexia or for male contraception
08/24/2010US7781461 Neuropeptide Y receptor antagonists comprising 4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide and a pharmaceutically acceptable carrier, used for the treatment of obesity and as anorexigenic agents
08/24/2010US7781428 Pyrazoline compounds
08/24/2010CA2423103C N-acylsulfonamide apoptosis promoters
08/19/2010WO2010092180A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/19/2010WO2010072734A3 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
08/19/2010US20100210704 3-alkoxy-1-phenylpyrazole derivatives and pesticides
08/19/2010US20100210690 N-(pyrazole-3-yl)-benzamide derivatives as glucokinase activators
08/19/2010US20100210617 Aryl-Alkylamines And Heteroaryl-Alkylamines As Protein Kinase Inhibitors
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010US20100210524 Novel estrogen receptor ligands
08/19/2010US20100210466 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,6-diones and cyclohexanetriones as novel herbicides
08/19/2010US20100210036 Ppar active compounds
08/19/2010CA2750793A1 Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/18/2010EP2217588A1 Inhibitors of histone deacetylase
08/18/2010EP2217566A1 Bis-(sulfonylamino) derivatives in therapy 066
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/18/2010EP2217232A1 4-[4-(2-adamantylcarbamoyl)-5-tert-butyl-pyrazol-1-yl]benzoic acid - 465
08/18/2010EP1611107B1 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders
08/18/2010CN101809000A Compounds with a combination of cannabinoid-CB1 antagonism and serotonin reuptake inhibition
08/18/2010CN101808995A Novel glucokinase activators and methods of using same
08/18/2010CN101808994A Compounds and methods for kinase modulation, and indications therefor
08/18/2010CN101808992A 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
08/18/2010CN101805292A Pyrazolines compound as well as application and preparation method thereof
08/18/2010CN101805291A 1-(4-isopropylbenzene-yl)-3-methyl-5-pyrazolone, preparation method and application thereof
08/18/2010CN101805290A Aminosulfonyl pyrazol compounds and applications thereof
08/18/2010CN101160128B Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
08/17/2010US7777052 Process for the preparation of Fipronil, an insecticide, and related pyrazoles
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776890 1H-indazole compounds
08/17/2010US7776884 Cyclic derivatives as modulators of chemokine receptors activity
08/17/2010US7776874 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 256